SHOULD ANTIBODIES TO DOMAIN I B2-GLYCOPROTEIN 1 BE INVESTIGATED IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)?

被引：1
|
作者：
Cheldieva, F. [1 ,2 ]
Reshetnyak, T. [1 ,2 ]
Cherkasova, M. [1 ]
Glukhova, S. [3 ]
Lila, A. [2 ]
Nasonov, E. [3 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Lab Thromboinflammat, Moscow, Russia
[2] Minist Hlth Russia, Russian Med Acad Continuing Profess Educ, Dept Rheumatol, Moscow, Russia
[3] VA Nasonova Res Inst Rheumatol, Dept Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2329
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0496
引用
收藏
页码：1374 / 1375
页数：2
相关论文
共 50 条
  • [31] IgG anti-β2 glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus:: Prevalence and clinical correlations
    Ong, SG
    Cheng, HM
    Soon, SC
    Goh, E
    Chow, SK
    Yeap, SS
    CLINICAL RHEUMATOLOGY, 2002, 21 (05) : 382 - 385
  • [32] Plasma markers of leukocyte and endothelial cell function in antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE)
    Roch, B
    Kopprasch, S
    Graessler, J
    Schröder, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 327 - 327
  • [33] NEW ONSET HYPERTENSION AND PROTEINURIA IN A PREGNANT WOMAN WITH ANTIPHOSPHOLIPID SYNDROME (APS) AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Scuorzo, Joseph
    Chong, Grace
    Duffy, Margaret
    Santoriello, Dominick
    D'Agati, Vivette
    Maynard, Sharon
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 632 - 632
  • [34] IgG Anti-β2 Glycoprotein I Antibodies in Malaysian Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus: Prevalence and Clinical Correlations
    S. G. Ong
    H. M. Cheng
    S. C. Soon
    E. Goh
    S. K. Chow
    S. S. Yeap
    Clinical Rheumatology, 2002, 21 : 382 - 385
  • [35] Premature atherosclerosis and cardiovascular events (CVE) in patients with systemic lupus erythematosus (SLE) with or without antiphospholipid syndrome (APS) and lupus nephritis (LN)
    Kozlovskaya, N. L.
    Serikova, S. Y.
    Shilov, E. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 133 - 133
  • [36] Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome
    Cousins, Laura
    Pericleous, Charis
    Khamashta, Munther
    Bertolaccini, Maria Laura
    Ioannou, Yiannis
    Giles, Ian
    Rahman, Anisur
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (01) : 317 - U444
  • [37] Polymorphism of β2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome
    Gushiken, FC
    Arnett, FC
    Ahn, C
    Thiagarajan, P
    ARTHRITIS AND RHEUMATISM, 1999, 42 (06): : 1189 - 1193
  • [38] Antibodies to beta(2)-glycoprotein I in patients with systemic lupus erythematosus: Reply
    Tsutsumi, A
    Matsuura, E
    Ichikawa, K
    Koike, T
    ARTHRITIS AND RHEUMATISM, 1997, 40 (07): : 1366 - 1367
  • [39] Antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome
    Salcido-Ochoa, F
    Cabiedes, J
    Alarcón-Segovia, D
    Cabral, AR
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2002, 8 (05) : 251 - 255
  • [40] Antiphosphatidylethanolamine antibodies and antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Balada, E
    Ordi-Ros, J
    Mauri, M
    Paredes, F
    Villarreal, J
    Labrador, M
    Vilardell, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S313 - S313
12345